Ligand validation:4CQQ

MPO: 3[N-MORPHOLINO]PROPANE SULFONIC ACID

MPO is a Ligand Of Interest in 4CQQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CQQ_MPO_B_1163	16%	13%	0.311	0.88	2.51	1.47	2	4	0	0	100%	1
4CQS_MPO_A_1331	42%	17%	0.178	0.899	2.5	1.12	2	1	0	0	100%	1
4CQP_MPO_B_1163	16%	17%	0.288	0.856	2.53	1.16	2	2	0	0	100%	1
4CQR_MPO_B_1166	11%	15%	0.276	0.791	2.45	1.37	2	2	0	0	100%	1
5AJM_MPO_B_1166	6%	15%	0.323	0.767	2.44	1.34	2	3	0	0	100%	1
4CQU_MPO_B_1163	6%	15%	0.33	0.768	2.5	1.31	2	2	0	0	100%	1
4MZC_MPO_A_201	100%	63%	0.031	0.998	0.43	0.98	-	1	0	0	100%	1
1KJQ_MPO_A_397	100%	25%	0.042	0.99	1.69	1.37	2	2	0	0	100%	1
1KJ9_MPO_A_400	100%	18%	0.046	0.988	2.1	1.42	2	3	0	0	100%	1
1KJI_MPO_A_398	99%	16%	0.052	0.989	1.99	1.7	2	3	0	0	100%	1
4LRQ_MPO_B_201	99%	9%	0.061	0.99	2.22	2.32	2	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.